Fresenius Dialysis - Carrollwood — Tampa, Florida

Fresenius Dialysis - Carrollwood is a clinical research site located in Tampa, Florida, United States 33624.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Fresenius Dialysis - Carrollwood has participated in 1 clinical trials.

Therapeutic areas: Chronic Kidney Disease (CKD) Stage 5, Hypertrophy, Left Ventricular.

Sponsors: Abbott.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fresenius Dialysis - Carrollwood?

Fresenius Dialysis - Carrollwood has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fresenius Dialysis - Carrollwood conducted?

Fresenius Dialysis - Carrollwood has 1 clinical trials on record. Their work covers Chronic Kidney Disease (CKD) Stage 5, Hypertrophy, Left Ventricular.

Is Fresenius Dialysis - Carrollwood accredited by Crixeo Health?

Fresenius Dialysis - Carrollwood has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fresenius Dialysis - Carrollwood?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.